287 related articles for article (PubMed ID: 18817932)
1. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
D'Souza M; Kappos L; Czaplinski A
J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome measures in multiple sclerosis.
Amato MP; Portaccio E
J Neurol Sci; 2007 Aug; 259(1-2):118-22. PubMed ID: 17376487
[TBL] [Abstract][Full Text] [Related]
3. Outcome measures in multiple sclerosis clinical trials.
Andersson PB; Goodkin DE
Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
[TBL] [Abstract][Full Text] [Related]
4. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
5. Disability as an outcome in MS clinical trials.
Ebers GC; Heigenhauser L; Daumer M; Lederer C; Noseworthy JH
Neurology; 2008 Aug; 71(9):624-31. PubMed ID: 18480462
[TBL] [Abstract][Full Text] [Related]
6. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
7. The use of MRI as an outcome measure in clinical trials.
Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes assessment in multiple sclerosis.
Rudick R; Antel J; Confavreux C; Cutter G; Ellison G; Fischer J; Lublin F; Miller A; Petkau J; Rao S; Reingold S; Syndulko K; Thompson A; Wallenberg J; Weinshenker B; Willoughby E
Ann Neurol; 1996 Sep; 40(3):469-79. PubMed ID: 8797541
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Goodin DS
Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
[TBL] [Abstract][Full Text] [Related]
12. The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.
Bermel RA; Fisher E; Cohen JA
Neuroimaging Clin N Am; 2008 Nov; 18(4):687-701, xi. PubMed ID: 19068409
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Ontaneda D; LaRocca N; Coetzee T; Rudick R;
Mult Scler; 2012 Aug; 18(8):1074-80. PubMed ID: 22740488
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis clinical trials: old and new challenges.
Noseworthy JH
Semin Neurol; 1998; 18(3):377-88. PubMed ID: 9817540
[TBL] [Abstract][Full Text] [Related]
15. Lessons from randomised direct comparative trials.
Achiron A; Fredrikson S
J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
[TBL] [Abstract][Full Text] [Related]
16. Redefining functionality and treatment efficacy in multiple sclerosis.
Foley JF; Brandes DW
Neurology; 2009 Jun; 72(23 Suppl 5):S1-11. PubMed ID: 19506262
[TBL] [Abstract][Full Text] [Related]
17. Scales as outcome measures for Alzheimer's disease.
Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
[TBL] [Abstract][Full Text] [Related]
18. Issues affecting the selection of participation measurement in outcomes research and clinical trials.
Whiteneck GG
Arch Phys Med Rehabil; 2010 Sep; 91(9 Suppl):S54-9. PubMed ID: 20801281
[TBL] [Abstract][Full Text] [Related]
19. Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment.
Heesen C; Romberg A; Gold S; Schulz KH
Expert Rev Neurother; 2006 Mar; 6(3):347-55. PubMed ID: 16533139
[TBL] [Abstract][Full Text] [Related]
20. What can be learned from open direct comparative trials in multiple sclerosis?
Khan O
J Neurol Sci; 2009 Feb; 277 Suppl 1():S25-8. PubMed ID: 19200861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
